Use of High- and Medium-Cut-off Membrane Hemodialysis for Removal of Free Light Chains in Patients with Multiple Myeloma—A Single-Center Experience
: Our data show that HCO/MCO-HD treatment alongside anti-myeloma therapy achieves sustained FLC reduction in newly diagnosed MM with AKI and early FLC reduction is highlighted as a key determinant of survival.
Authors
- Barbara Vajdič Trampuž
- Jakob Gubenšek (ORCID: https://orcid.org/0000-0002-5394-3729)
- Matevž Škerget (ORCID: https://orcid.org/0000-0002-6283-9720)
- Tajda Starman
Institutions
- University of Ljubljana (SI)
- Ljubljana University Medical Centre (SI)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-04-11
- DOI
- https://doi.org/10.3390/jcm15082917
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Javna Agencija za Raziskovalno Dejavnost RS